Home intravenous antibiotic therapy and allergic drug reactions: Is there a case for routine supply of anaphylaxis kits?

Journal of Infusion Nursing

Volumn 27, Issue 6, 2004, Pages 425-430

  Dodson, Pauline M ^a,b   Boyle, Michael ^a,b,c   Loewenthal, Mark ^a,b,d  

^a JOHN HUNTER HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c Immunology

^d Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ADRENALIN; AMIKACIN; AMPHOTERICIN; ANTIBIOTIC AGENT; AZTREONAM; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; FLUCLOXACILLIN; GANCICLOVIR; GENTAMICIN; IMIPENEM; MEROPENEM; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; TICARCILLIN; TIMENTIN; TOBRAMYCIN; VANCOMYCIN;

ABSCESS; ACTINOMYCOSIS; ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL ENDOCARDITIS; BRONCHIECTASIS; BURSITIS; CATHETER INFECTION; CELLULITIS; CHILD; CHOLANGITIS; CYSTIC FIBROSIS; DIARRHEA; DISKITIS; DRUG HYPERSENSITIVITY; EMPYEMA; ENCEPHALITIS; EPIGLOTTITIS; FEMALE; GASTRITIS; HOME CARE; HUMAN; INFANT; INTESTINE LIPODYSTROPHY; LEMIERRE SYNDROME; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NECROTIZING FASCIITIS; OSTEOMYELITIS; OTITIS MEDIA; OUTPATIENT CARE; PAROTITIS; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; PROSTHESIS INFECTION; PRURITUS; PYELONEPHRITIS; RASH; SEPTICEMIA; SERUM SICKNESS; SINUSITIS; SYPHILIS; ULCERATIVE COLITIS; URINARY TRACT INFECTION; VOMITING; WOUND INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANAPHYLAXIS; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG HYPERSENSITIVITY; EPINEPHRINE; FEMALE; HOME INFUSION THERAPY; HUMANS; INCIDENCE; INFANT; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEW SOUTH WALES; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 8844244721     PISSN: 15331458     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129804-200411000-00008     Document Type: Article

References (26)

1. Kunkel MJ. Quality assurance and outcomes in outpatient parenteral antibiotic therapy. Infect Dis Clin North Am. 1998;12(4):1023-1034.
2. Anonymous. Executive summary of disease management of drug hypersensitivity: a practice parameter. Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 1999;83(6 Pt 3):665-700.
3. Erffremeyer JE. Reactions to antibiotics. Immunol Allergy Clin North Am. 1992;12(3):633-648.
4. Pumphrey RS, Davis, S. Underreporting of antibiotic anaphylaxis may put patients at risk. Lancet. 1999;353(9159):1157-1158.
5. Hoffman-Terry ML, Fraimow HS, Fox TR, Swift BG, Wolf JE. Adverse effects of outpatient parenteral antibiotic therapy. Am J Med. 1999;106:44-49.
6. Gomez M, Maraqa N, Alvarez A, Rathore M. Complications of outpatient parenteral antibiotic therapy in childhood. Pediatr Infect Dis J. 2001;20(5):541-543.
7. Dahlgren AF. Adverse drug reactions in home patients receiving nafcillin or oxacillin. Am J Health Syst Pharm. 1997;54:1176-1179.
8. Tice AD. Experience with a physician-directed, clinic-based program for outpatient parenteral antibiotic therapy in the USA. Eur J Clin Microbiol Infect Dis. 1995;14:655-661.
9. Sullivan T. Drug allergy. In: Middleton E, Reed C, Ellis E, et al, eds. Allergy Principles and Practice. 4th ed. St. Louis: Mosby-Year Book; 1993:1726-1746.
10. Tice AD, Hoaglund PA, Nolet B, McKinnon PS, Mozaffari E. Cost perspectives for outpatient intravenous antimicrobial therapy. Pharmacotherapy. 2002;22(2s):63s-70s.
11. Berman SJ, Johnson EW. Outpatient parenteral antibiotic therapy (OPAT): clinical outcomes and adverse effects. Hawaii Med J. 2001;60:31-33.
12. Rehm SJ, Longworth DL. Rates of adverse events associated with community-based parenteral antiinfective therapy. J Clin Outcomes Manage. 2000;7(10):23-28.
13. Bernard L, El-hajj, Pron B, et al. Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost. J Clin Pharm Ther. 2001;26:445-451.
14. Adkinson NF. Drug allergy. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy Principles and Practice. 5th ed. St. Louis: Mosby; 1998.
15. Hammond D. Home intravenous antibiotics: the safety factor. J Intraven Nurs. 1998;21(2):81-95.
16. Goldberg A, Confino-Cohen R. Insect sting-inflicted systemic reactions: attitudes of patients with insect venom allergy regarding after-sting behavior and proper administration of epinephrine. J Allergy Clin Immunol. 2000;106:1184-1189.
17. Anderson JA. The allergist's responsibilities in anaphylaxis: documentation, prevention, and patient and public education. Immunol Allergy Clin North Am. 2001;21(4):827-839.
18. Sabroe RA, Glendinning AK, Sabroe I, Lawlor F, Kobza Black A. An audit of the use of self-administered adrenaline syringes in patients with angio-oedema. Br J Dermatol. 2002;146(4):615-620.
19. Gold MS, Sainsbury R. First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen). J Allergy Clin Immunol. 2000;106:171-176.
20. Sicherer SH, Forman JA, Noone SA. Use assessment of self-administered epinephrine among food-allergic children and pediatricians. Pediatrics. 2000;105(2):359-362.
21. Mrvos R, Anderson BD, Krenzelok EP. Accidental injection of epinephrine from an autoinjector: invasive treatment not always required. South Med J. 2002;95(3):318-320.
22. Saff R, Nahhas A, Fink JN. Myocardial infarction induced by coronary vasospasm after self-administration of epinephrine. Ann Allergy. 1993;70(5):396-398.
23. Simons FE, Gu X, Silver NA, Simons KJ. EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis. J Allergy Clin Immunol. 2002;109(1):171-175.
24. Pumphrey RSH. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000;30(8):1144-1150.
25. Lin RY. A perspective on penicillin allergy. Arch Intern Med. 1992;152:930-937.
26. Pumphrey RSH. Fatal posture in anaphylactic shock. J Allergy Clin Immunol. 2003;112(2):451-452.